← Leaderboards
Gabriela Voskerician
Optima Integrated Health, Inc.
$7,090,025
Attributed
$7,090,025
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,090,025 · 6
By mechanism
R44$6,641,040 · 4
R43$448,985 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Michael P Harms · Washington University$13,645,932
- Xinhua Li · Nano Terra, Inc.$11,941,250
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,324,161
- Katherine Teresa Mills · Tulane University Of Louisiana$11,000,903
- Colin Masters · University Of Melbourne$10,651,748
Research focus
HypertensionResponseHeart FailureConfidential InformationSan FranciscoDiagnosisProtocols DocumentationCaringLogicBaseStrokePhysiciansMyocardial InfarctionPharmaceutical PreparationsIncidenceCommercial ApplicationComorbidityGuidelinesAlgorithmsElectronic Health RecordHypertension TreatmentBlood PressureGenderGenerations
Grant awards (10)
PERSEVERE-PEF: optimizing medical therapy saves lives in heart failure with preserved ejection fraction$1,246,428
R44 · FY2023 · HL · contact PI
PERSEVERE-PEF: optimizing medical therapy saves lives in heart failure with preserved ejection fraction$1,034,876
R44 · FY2022 · HL · contact PI
PROTECT: optima4BP 2.0: prediction of Optimal Treatment and Route to achieve and maintain BP Target$715,983
R44 · FY2021 · HL · contact PI
PROTECT: optima4BP 2.0: prediction of Optimal Treatment and Route to achieve and maintain BP Target$750,249
R44 · FY2020 · HL · contact PI
ARTERY Outcomes: tAilored dRug Titration through artificial intElligence: an inteRventional studY$654,816
R44 · FY2020 · HL · contact PI
ARTERY Outcomes: tAilored dRug Titration through artificial intElligence: an inteRventional studY$739,992
R44 · FY2019 · HL · contact PI
optima4heart: pharmacological intervention and transition of care in cardiovascular disease management$224,895
R43 · FY2019 · HL · contact PI
Tailored Drug Titration through Artificial Intelligence$649,649
R44 · FY2018 · HL · contact PI
HEART: Adding Memory to Reasoning: macHine lEArning tailoRed drug Titration$224,090
R43 · FY2018 · HL · contact PI
Tailored Drug Titration through Artificial Intelligence$849,047
R44 · FY2017 · HL · contact PI